Loading...

← Back to Leaderboard

Anirban Basu

Global rank #4657 94%

Institution: University of Washington -Depts of Pharmacy, Health Services, Economics

Primary Field: Health (weighted toward more recent publications)

Homepage: http://faculty.washington.edu/basua

First Publication: 2004

Most Recent: 2015

RePEc ID: pba977 ↗

Publication Scores

Scores use coauthorship adjustment: α/n credit per paper, where n = number of authors. α = 2.01: calibrated so average adjusted count equals average raw count (a zero-sum adjustment).

Period S (4x) A (2x) B (1x) C (½x) Total
Last 5 Years 0.00 0.00 0.00 0.00 0.00
Last 10 Years 0.00 0.00 0.00 0.00 0.00
All Time 0.00 0.00 14.81 0.00 14.81

Publication Statistics

Raw Publications 15
Coauthorship-Adjusted Count 14.88

Publications (15)

Year Article Journal Tier Authors
2015 Welfare implications of learning through solicitation versus diversification in health care Journal of Health Economics B 1
2014 HETEROGENEITY IN ACTION: THE ROLE OF PASSIVE PERSONALIZATION IN COMPARATIVE EFFECTIVENESS RESEARCH Health Economics B 5
2014 RESPONSE TO EPSTEIN'S COMMENT ON “HETEROGENEITY IN ACTION” Health Economics B 5
2014 CAN WE MAKE SMART CHOICES BETWEEN OLS AND CONTAMINATED IV METHODS? Health Economics B 2
2014 ESTIMATING PERSON‐CENTERED TREATMENT (PeT) EFFECTS USING INSTRUMENTAL VARIABLES: AN APPLICATION TO EVALUATING PROSTATE CANCER TREATMENTS Journal of Applied Econometrics B 1
2013 HIGHLIGHTING DIFFERENCES BETWEEN CONDITIONAL AND UNCONDITIONAL QUANTILE REGRESSION APPROACHES THROUGH AN APPLICATION TO ASSESS MEDICATION ADHERENCE Health Economics B 2
2011 Economics of individualization in comparative effectiveness research and a basis for a patient-centered health care Journal of Health Economics B 1
2011 The impact of comparative effectiveness research on health and health care spending Journal of Health Economics B 3
2011 Erratum: Estimating lifetime or episode‐of‐illness costs under censoring Health Economics B 2
2010 Estimating lifetime or episode‐of‐illness costs under censoring Health Economics B 2
2008 Two-stage residual inclusion estimation: Addressing endogeneity in health econometric modeling Journal of Health Economics B 3
2006 Scale of interest versus scale of estimation: comparing alternative estimators for the incremental costs of a comorbidity Health Economics B 3
2005 Generalized modeling approaches to risk adjustment of skewed outcomes data Journal of Health Economics B 3
2005 Implications of spillover effects within the family for medical cost-effectiveness analysis Journal of Health Economics B 2
2004 Comparing alternative models: log vs Cox proportional hazard? Health Economics B 3